“Clinical Evaluation in Adult Human Revealed the Biosimilarity of Recombinant Erythropoietin GBPD002 With Eprex®”. 2023. Archives of Clinical and Biomedical Research 7 (4): 459-74. https://fortunejournals.org/ojs/index.php/acbr/article/view/15029.